Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01401
|
|||||
Drug Name |
Tenoxicam
|
|||||
Synonyms |
Artriunic; Liman; Mobiflex; Reutenox; Tenoxicamum; Tilcotil; Apotex brand of tenoxicam; Novag brand of tenoxicam; Novopharm brand of tenoxicam; Roche brand of tenoxicam; Solvay brand of tenoxicam; Apo-Tenoxicam; Mobiflex (TN); Novo-Tenoxicam; Ro 12-0068; Ro-120068; Tenoxicamum [INN-Latin]; Tilcotil (TN); Ro 12-0068/000; Ro-12-0068; Tenoxicam (JAN/USAN/INN); Tenoxicam [USAN:BAN:INN:JAN]; (3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; (3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; 2H-Thieno(2,3-e)-1,2-thiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; 3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; 4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-THIENO[2,3-E]-1,2-THIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE; 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide1,1-dioxide; 4-Hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide; 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Rheumatoid arthritis [ICD11: FA20] | Approved | [1] | |||
Therapeutic Class |
Antiinflammatory Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C13H11N3O4S2
|
|||||
Canonical SMILES |
CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3
|
|||||
InChI |
InChI=1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)
|
|||||
InChIKey |
LZNWYQJJBLGYLT-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 59804-37-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 337.4 | Topological Polar Surface Area | 136 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 2 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
1.1
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:32192
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | National Center for Advancing Translational Science-Inxight: drug (Z1R9N0A399) | |||||
2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.